Consequences of menopause in women with diabetes mellitus - a clinical problem

被引:7
作者
Jedrzejuk, D [1 ]
Milewicz, A [1 ]
机构
[1] Wroclaw Med Univ, Dept Endocrinol Diabetol & Isotpoe Therapy, PL-50367 Wroclaw, Poland
关键词
menopause; diabetes mellitus;
D O I
10.1080/09513590500378964
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Human life was prolonged by 30 years in the past century, with the result that about 40% of a woman's life falls within the postmenopausal period. The consequences, both early and remote, in the form of cardiovascular disease, osteoporosis and neoplastic disease are most pronounced in women suffering from one of the most common diseases, i.e., diabetes mellitus and the metabolic syndrome preceding it. These patients are problematic for physicians, and for this reason a study of diagnostic and therapeutic management was undertaken on the basis of our own experience as well as examination based on evidence-based medicine. Prior to making therapeutic decisions it is necessary to determine cardiovascular, thromboembolic and breast cancer risk factors. Hormonal therapy may be helpful in young postmenopausal women who are free of risk factors, and its composition and route of administration are significant considerations. Women with risk factors and who are more than 10 years after menopause should be administered alternative therapy depending on the diagnosed pathology.
引用
收藏
页码:280 / 286
页数:7
相关论文
共 67 条
[11]   Differential effects of oral estrogen versus oral estrogen-androgen replacement therapy on body composition in postmenopausal women [J].
Dobs, AS ;
Nguyen, T ;
Pace, C ;
Roberts, CP .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (04) :1509-1516
[12]   ESSENTIAL-HYPERTENSION, METABOLIC DISORDERS, AND INSULIN RESISTANCE [J].
FERRANNINI, E ;
NATALI, A .
AMERICAN HEART JOURNAL, 1991, 121 (04) :1274-1282
[13]   Current use of unopposed estrogen and estrogen plus progestin and the risk of acute myocardial infarction among women with diabetes - The Northern California Kaiser Permanente Diabetes Registry, 1995-1998 [J].
Ferrara, A ;
Quesenberry, CP ;
Karter, AJ ;
Njoroge, CW ;
Jacobson, AS ;
Selby, JV .
CIRCULATION, 2003, 107 (01) :43-48
[14]   Hormone replacement therapy is associated with better glycemic control in women with type 2 diabetes - The Northern California Kaiser Permanente Diabetes Registry [J].
Ferrara, A ;
Karter, AJ ;
Ackerson, LM ;
Liu, JY ;
Selby, JV .
DIABETES CARE, 2001, 24 (07) :1144-1150
[15]   Systemic hypertension in postmenopausal women: A clinical approach [J].
Fisman, EZ ;
Tenenbaum, A ;
Pines, A .
CURRENT HYPERTENSION REPORTS, 2002, 4 (06) :464-470
[16]   Diabetes as a risk factor for death following endometrial cancer [J].
Folsom, AR ;
Anderson, KE ;
Sweeney, C ;
Jacobs, DR .
GYNECOLOGIC ONCOLOGY, 2004, 94 (03) :740-745
[17]  
Freedland E.S., 2004, NUTR METAB, V1, P1
[18]   INSULIN-RESISTANCE, SECRETION, AND ELIMINATION IN POSTMENOPAUSAL WOMEN RECEIVING ORAL OR TRANSDERMAL HORMONE REPLACEMENT THERAPY [J].
GODSLAND, IF ;
GANGAR, K ;
WALTON, C ;
CUST, MP ;
WHITEHEAD, MI ;
WYNN, V ;
STEVENSON, JC .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (07) :846-853
[19]  
Guastamacchia E., 2003, Current Drug Targets - Immune Endocrine and Metabolic Disorders, V3, P205, DOI 10.2174/1568008033340199
[20]   Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women [J].
Hayward, CS ;
Samaras, K ;
Campbell, L ;
Kelly, RP .
AMERICAN JOURNAL OF HYPERTENSION, 2001, 14 (07) :699-703